• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Kentucky Attorney General's Office Emphasizes Strict Editorial Standards

chest

The Kentucky Attorney General's Office has released a report emphasizing strict editorial standards focusing on accuracy, relevance, and impartiality.

user avatarKaterina Papadopoulou

Water.org Launches Get Blue Campaign

chest

Water.org has launched the Get Blue campaign to expand access to safe water through consumer participation and brand partnerships.

user avatarLeo van der Veen

Matt Damon to Speak at Ripple Swell 2026

chest

Matt Damon will be a keynote speaker at Ripple Swell 2026, highlighting the intersection of finance and philanthropy.

user avatarMaya Lundqvist

New Report on Ethereum EIP Specifications Released

chest

A report based on Ethereum EIP specifications has been published, providing valuable insights and updates for the Ethereum community.

user avatarLi Weicheng

Altcoins Experience Significant Selling Pressure

chest

Altcoins are experiencing significant selling pressure, with a cumulative buy-sell volume difference of approximately 209 billion, indicating weak market conditions.

user avatarAisha Farooq

Canary Capitals Launches Litecoin ETF Amid Slow Demand

chest

Canary Capitals has launched its Litecoin ETF, LTCC, but initial demand is limited compared to Bitcoin and Ethereum ETFs, with only $93 million in inflows.

user avatarTenzin Dorje

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.